200-Day Moving Average Scanner
Find stocks near, above, below, or reclaiming their 200-day moving average — a long-term support and trend signal used by institutional desks.
Position relative to 200-DMA
Filter by ±2%, ±5%, ±10% bands around the long-term moving average.
Reclaim setups
Spot stocks crossing back above the 200-DMA on rising volume — classic trend reversal.
Multi-MA stack
Cross-check with 50-day and 100-day averages for trend confirmation.
Sample scan output
Illustrative data — for educational use| Ticker | Company | Category | Price | Pullback % | RSI | Bollinger | 50-Day MA | 100-Day MA | 200-Day MA | Score | Signal | Risk Level |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | $152.40 | -12.3% | 31 | Lower band | Below | Below | Near | 88 | Stage 2 Add | Low |
| MSFT | Microsoft | Software | $402.10 | -9.1% | 38 | Mid band | Above | Above | Above | 82 | Stage 1 Starter | Low |
| KO | Coca-Cola | Staples | $58.92 | -8.7% | 34 | Lower band | Below | Near | Above | 79 | Stage 1 Starter | Low |
| PEP | PepsiCo | Staples | $163.20 | -15.4% | 29 | Below lower | Below | Below | Below | 84 | Stage 3 Strong | Low |
| NKE | Nike | Consumer | $74.55 | -32.1% | 27 | Below lower | Below | Below | Below | 71 | Watch | Medium |
| UNH | UnitedHealth | Healthcare | $498.10 | -22.4% | 33 | Lower band | Below | Below | Near | 86 | Stage 2 Add | Low |
| LMT | Lockheed Martin | Defense | $455.70 | -11.8% | 41 | Mid band | Above | Near | Above | 80 | Stage 1 Starter | Low |
| TXN | Texas Instruments | Semiconductor | $178.30 | -13.6% | 36 | Lower band | Near | Above | Above | 77 | Stage 1 Starter | Low |
Ready to scan live data?
Start a free scan on a curated universe of high-quality stocks. Upgrade for the full 130-stock scanner, watchlist sync, and daily alerts.
Related scanners & agents
This tool is for educational stock research only. It does not provide financial advice, investment advice, tax advice, legal advice, or personalized recommendations. It does not place trades. Users should do their own research and consult a licensed financial advisor before making investment decisions.